TAG to Honor Gloria Reuben, Dr. Jeanne Marrazzo, and Richard Lynn at the 2025 Research in Action Awards
TAG’s annual Research in Action Awards is our most anticipated night of the year.
Vivid Coffee Partnership
We’re proud to partner with Vivid Coffee, a Vermont-based specialty roastery and café, on the creation of the T.A.G. Blend.
TAG’s Comments for the September 2025 Meeting of the Advisory Committee on Immunization Practices (Docket No. CDC-2025-0454)
TAG letter urging the Advisory Committee on Immunization Practices (ACIP) to maintain the recommendation of a universal hepatitis B virus (HBV) birth dose vaccine in the United States.
Joint Statement Calling for Secretary Kennedy Resignation
On Sept. 3 20+ organizations — including TAG — signed this Infectious Diseases Society of America’s (IDSA) joint statement calling for the resignation of Sec. Robert F. Kennedy Jr. The letter outlines the many ways Kennedy’s “agenda” is meant to undermine science and public health.
RIAA 2025 Limited Edition Artist, Matthew Leifheit
Matthew Leifheit is an American photographer, magazine editor, and professor based in Brooklyn, New York. A graduate of Rhode Island School of Design and the Yale School of Art, Leifheit is Editor-in-Chief of MATTE Magazine, the journal of emerging photography…
TAG Statement on the Criminalization of Homelessness and Drug Use, and the Cure Hepatitis C Act of 2025
The current administration’s Executive Order on Ending Crime and Disorder on America’s streets is yet another direct attack on science and basic human rights.
Treatment Action Group Statement on Suspension of TB Funding Over White House Gain-of-Function Fictions
Treatment Action Group (TAG) opposes in the strongest possible terms the suspension of at least 22 TB research awards by the National Institutes of Health (NIH) following a May 2025 White House executive order banning “gain-of-function” research.
A Deep Dive Into the HCV Elimination Bill: How Communities Can Secure a Win
TAG is organizing this webinar on July 29 for community organizations and advocates to raise awareness about the HCV Elimination bill, and prepare them to meet and engage with their Senators during the August recess in their district offices or Town Hall meetings.
Congressional Briefing on Lifesaving NIH Infectious Disease Research
TAG was among thirteen organizations that cosponsored this Congressional briefing held on July 9, 2025. Briefing materials and presentations are available for download.
TAG to Honor Founding Member and Activist Dr. Richard Lynn as Third and Final Honoree at 2025 Research in Action Awards
Treatment Action Group (TAG) is proud to announce Dr. Richard Lynn — scientist, activist, philanthropist, and founding member of TAG — as the third and final honoree for the 2025 Research in Action Awards (RIAA), to be held on October 20 at the Angel Orensanz Foundation in New York City.